Japan's healthcare system and pharmaceutical industry

Journal of Generic Medicines

Volumn 4, Issue 1, 2006, Pages 23-29

  Saigusa, Osamu ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; ISONIAZID; STREPTOMYCIN;

ARTICLE; COST CONTROL; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG USE; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH PROGRAM; HUMAN; INFANT MORTALITY; JAPAN; LIFESPAN; NUTRITIONAL STATUS; TUBERCULOSIS;

EID: 33846860584     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4950039     Document Type: Article

References (5)

1. Special healthcare system for seniors (SHSS) will be reformed to a more efficient one from April 2008.
2. Riku, J. Current situation for generic drugs in Japan. (2005) J. Generic Med. 2(3), 219-231.
3. JGPMA Presentation at The 9th Annual IGPA Conference by Dr.Norihiro Kawamura available at Japan Generic Pharmaceutical Manufacturers Association home page TOPICS (www.jgpma.gr.jp/index.html).
4. Ministry of Health, Labor and Welfare (MHLW) (2006). Annual Reports on Health and Welfare available at www.mhlw.go.jp/english.
5. Data Book 2006, Japan Pharmaceutical Manufacturers Association, Tokyo, Japan.